{"id":2377,"date":"2019-10-05T21:59:40","date_gmt":"2019-10-05T19:59:40","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2377"},"modified":"2024-04-10T15:52:32","modified_gmt":"2024-04-10T13:52:32","slug":"angiogenesi-tumoral","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-cancer\/programa-de-mecanismes-molleculars-i-terapia-experimental-en-oncologia-oncobell\/angiogenesi-tumoral\/","title":{"rendered":"Angiog\u00e8nesi Tumoral"},"content":{"rendered":"\n
Peix,F;Casanovas,O, Promalignant effects of antiangiogenics in the tumor microenvironment<\/strong>., Semin. Cancer Biol., 2022;86(Pt 3):199-206, doi:10.1016\/j.semcancer.2022.03.003<\/p>\n S\u00e1nchez Guix\u00e9,M;Hierro,C;Jim\u00e9nez,J;Viaplana,C;Villacampa,G;Monelli,E;Bras\u00f3 Maristany,F et al, High FGFR1-4 mRNA expression levels correlate with response to selective FGFR inhibitors in breast cancer<\/strong>., Clin. Cancer Res., 2022;28(1):137-149, doi:10.1158\/1078-0432.CCR-21-1810<\/p>\n\n\t\t\t\t\tProjectes seleccionats<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t 20MEC018. Targeteando la Coagulaci\u00f3n en la formaci\u00f3n de met\u00e1stasis en c\u00e1ncer renal. Ministerio de Ciencia e Innovaci\u00f3n<\/strong>. Budget: 145200. 2020-2023. PI: Casanovas Casanovas, Oriol.<\/p>\n 20MAR004. Identification of Kidney Cancer progression targets and biomarkers through CRISPRengineered organoids and xenograft mouse models<\/strong>. Fundaci\u00f3 La Marat\u00f3 de TV3. Budget: 136250. 2020-2023. PI: Casanovas Casanovas, Oriol.<\/p>\n AEC21003. Angiotheragnostics (AtG): Developing a First-in-Class anticancer treatment with its patient selection biomarker for patients with advanced kidney cancer<\/strong>. Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC). Budget: 180000. 2021-2023. PI: Casanovas Casanovas, Oriol.<\/p>\n FIS21102. ANGIOTHERAGNOSTICS: DESARROLLO DE UN NUEVO TRATAMIENTO CON SU BIOMARCADOR DE SELECCI\u00d3N DE PACIENTES PARA PACIENTES CON C\u00c1NCER COLORECTAL AVANZADO<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 149600. 2022-2023. PI: Casanovas Casanovas, Oriol.<\/p>\n MCI21016. Desarrollo de un nuevo biomarcador y su ‘kit’ prototipo para predecir la Respuesta Agresiva en Cancer<\/strong>. Ministerio de Ciencia e Innovaci\u00f3n. Budget: 132250. 2021-2023. PI: Casanovas Casanovas, Oriol.<\/p>\n\t\t\t\t\tTransfer\u00e8ncia de tecnologia<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tPAT041: “PD-ECGF AS BIOMARKER OF CANCER” Beca Proof of Concept (PoC) 2015 de l’European Research Council – Oriol Casanovas.<\/p>\nMapping the pathogenesis of vascular malformation<\/strong>s Angiog\u00e8nesi Tumoral Resum El nostre grup de recerca en el Programa ProCURE (Institut Catal\u00e0 d’Oncologia) i el Programa OncoBell (IDIBELL) se centra a determinar les conseq\u00fc\u00e8ncies de l’adaptaci\u00f3 i la resist\u00e8ncia a la ter\u00e0pia contra el c\u00e0ncer antiangiog\u00e8nic. Per a aix\u00f2, utilitzem la investigaci\u00f3 traslacional en models murins de c\u00e0ncer, particularment els models PDOX de […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":448,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-04 23:24:02","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2377"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=2377"}],"version-history":[{"count":6,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2377\/revisions"}],"predecessor-version":[{"id":25396,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2377\/revisions\/25396"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/448"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=2377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nIP: Oriol Casanovas
\nEP15382109\nPAT080-“METHODS FOR PREDICTING THE RISK OF LOCAL INVASION AND\/OR METASTASIS INDUCED BY AN ANTIANGIOGENIC TREATMENT”
\nIP: Oriol Casanovas
\nEP20382600\nPAT088: PYRIMIDINE-1,3-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF
\nCANCER
\nIP: Oriol Casanovas
\nEP23382217\nLicense: PD- ECGF AS BIOMARKER OF CANCER
\nPI: Dr. Oriol Casanovas\nSpin-off: AtG Therapeutics
\nPI: Dr. Oriol Casanovas\n\t\t\t\t\tM\u00e9s informaci\u00f3<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t
\nIP:\u00a0Graupera Garcia-Mila, Mariona (Project Leader)
\nSocis:\u00a0Centro Nacional de Investigaciones Cardiovasculares-CNIC (Dr. R. Benedito), Hospital Santa Creu Sant Pau (Dra. E. Baselga) i Sant Joan de D\u00e9u (Dr. J. Mora)
\nConvocat\u00f2ria:\u00a0Health Research 2018 Call for proposals, expediente: HR18-00120
\nEntitat Finan\u00e7adora: Fundaci\u00f3 “la Caixa”
\n\n\t\t\t\t\n\n\t\tCasanovas Casanovas, Oriol\n\t<\/h4>\n
\n\t\t\n\t\tocasanovas@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t\n
\n\t\tCasanovas Casanovas, Oriol\n\t<\/h4>\n
\n\t\t\n\t\tocasanovas@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tENLLA\u00c7OS RELACIONATS\n\t<\/h4>\n
\n\t\t\n\t\tProCURE\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\t @AngioTxDx\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tCaps de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es postdoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as predoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSuport cient\u00edfic\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tCol\u00b7laboradors\/es\t\t\t\t<\/a>\n\t\t\t\t\t\tCaps de grup\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n
\n
\n\t\tNot\u00edcies relacionades\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tCom la ter\u00e0pia antiangiog\u00e8nica pot augmentar l’agressivitat dels tumors?<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t29\/03\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tL’IDIBELL rep m\u00e9s d’un mili\u00f3 i mig d’euros de l’AECC per finan\u00e7ar projectes d’investigaci\u00f3 contra el c\u00e0ncer<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t17\/11\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEls models animals de xenograf recapitulen el comportament gen\u00e8tic dels tumors humans originals<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t28\/01\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tIDIBELL celebra el Kickoff Meeting dels projectes finan\u00e7ats per La Fundaci\u00f3 La Marat\u00f3 de TV3 2019<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t18\/11\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tIdentificat un biomarcador que preveu l’increment de malignitat que pot causar la ter\u00e0pia antiangiogenica en els c\u00e0ncer renals<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t05\/11\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa Marat\u00f3 impulsa 43 projectes sobre el c\u00e0ncer en la inversi\u00f3 anual en recerca m\u00e9s gran de la seva hist\u00f2ria<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t31\/10\/2019\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tL’IDIBELL i Sant Joan de D\u00e9u uneixen forces per crear el primer model animal de la S\u00edndrome Sturge-Weber<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t21\/10\/2019\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tTres investigadores IDIBELL reben ajuts de la Fundaci\u00f3 Banc\u00e0ria “la Caixa” per a impulsar projectes de recerca pionera i de gran impacte social<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t17\/09\/2019\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tInvestigadors de l’IDIBELL-ICO descriuen un nou mecanisme de resist\u00e8ncia a ter\u00e0pies que impedeixen la formaci\u00f3 de vasos sanguinis<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t02\/07\/2019\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDescobert el mecanisme d’acci\u00f3 del gen clau per a la formaci\u00f3 dels vasos sanguinis implicat en c\u00e0ncer i malformacions vasculars<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t21\/11\/2018\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"